Amiloride Sensitizes Prostate Cancer Cells to the Reversible Tyrosine Kinase Inhibitor Lapatinib by Modulating ERBB3 Subcellular Localization
Maitreyee K. Jathal(University of California, Davis), P. Ghosh(The University of Texas Health Science Center at San Antonio)
Cited by 0
Related Papers
Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation
|Endocrine Related Cancer|2005|109
Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase
|British Journal of Cancer|2019|23
Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer
|Endocrine Related Cancer|2015|21
Androgen receptor transcriptional activity is required for heregulin-1β–mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase
|Journal of Biological Chemistry|2023|7
Alterations in Tumor Aggression Following Androgen Receptor Signaling Restoration in Canine Prostate Cancer Cell Lines
|International Journal of Molecular Sciences|2024|1